← SynDRA
GLYCOPYRRONIUM
SynDRA canonical compound SYN0023542 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | CHRM3 |
| Mechanism of action | Acetylcholine receptor antagonist |
| Indication | peptic ulcer disease (PUD) |
| Disease area | gastroenterology |
All known targets
- CHRM1
- CHRM3
- CHRM2
- CHRM4
- CHRM5
Mechanisms of action (all sources)
- Acetylcholine receptor antagonist
- CHRM3 ANTAGONIST
- Muscarinic acetylcholine receptor M3 antagonist
- CHRM1 ANTAGONIST
- Muscarinic acetylcholine receptor M1 antagonist
- CHRM2 ANTAGONIST
- CHRM4 ANTAGONIST
- CHRM5 ANTAGONIST
Drug classes
- Cholinergic Antagonists
- Anticholinergic
- Adjuvants, Anesthesia
- Central Nervous System Agents
- Cholinergic Agents
- Muscarinic Antagonists
- Neurotransmitter Agents
ATC classes
- A03A · DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
- R03B · OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
- D11A · OTHER DERMATOLOGICAL PREPARATIONS
- ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS
- ADRENERGICS, INHALANTS
Cross-references
Synonyms
- glycopyrronium bromide
- sialanar
- NVA237
- Seebri Breezhaler
- copyrrolate
- gastrodyn
- glycopyrrolate
- robanul
- glycopyrrolate bromide
- glycopyrronium tosilate
- glycopyrronium tosilate hydrate
- Glycopyrrolate cation
- Glycopyrrolate ion
- Glycopyrronium cation
- Glycopyrronium ion
- Glycopyrronium, erythro-
- A14FB57V1D
- RefChem:922362
- Robinal
- NCGC00179456-02
- Tovanor Breezhaler
- Prestwick0_000746
- Prestwick1_000746
- Prestwick2_000746
- Prestwick3_000746
- BSPBio_000732
- SCHEMBL133002
- SPBio_002671
- BPBio1_000806
- GTPL7459
- CHEBI:94449
- ANGKOCUUWGHLCE-UHFFFAOYSA-N
- Qbrexza® (glycopyrronium cloth)
- BDBM50417445
- MRF-0000310
- NCGC00179456-01
- SBI-0206947.P001
- AB00513912
Reported adverse events
- Injection site reaction
- Headache
- Sinusitis
- Constipation
- Pneumonia
- Vomiting
- Agitation
- Flushing
- Dry skin
- Irritability
- Dehydration
- Heart rate
Look up GLYCOPYRRONIUM in the interactive SynDRA portal →